We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
(+10%)
Cap. Flow
+$812M
Cap. Flow
% of AUM
7.54%
Top 10 Holdings %
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$32.7M |
| 2 |
Eli Lilly
LLY
|
+$31M |
| 3 |
La-Z-Boy
LZB
|
+$17.4M |
| 4 |
Ubiquiti
UI
|
+$17.1M |
| 5 |
TriMas Corp
TRS
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LSB Industries
LXU
|
+$14M |
| 2 |
K
Kellanova
K
|
+$13.7M |
| 3 |
Apple
AAPL
|
+$13.1M |
| 4 |
Prosperity Bancshares
PB
|
+$11.7M |
| 5 |
Fluor
FLR
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.72% |
| 2 | Industrials | 12.7% |
| 3 | Healthcare | 12.22% |
| 4 | Financials | 10.93% |
| 5 | Energy | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Bank of America
BAC
$435B
| $10.4M | 0.1% |
603,458
+16,239
| +3% | +$273K |
|
277
Goldman Sachs
GS
$313B
| $10.4M | 0.1% |
63,181
-13,774
| -18% | -$2.32M |
|
|
INN
278
Summit Hotel Properties
INN
$761M
| $10.3M | 0.1% |
+1,109,125
| New | +$10M |
|
279
Valero Energy
VLO
$89.8B
| $10.3M | 0.1% |
193,642
+25,488
| +15% | +$1.3M |
|
|
CMA
280
DELISTED
Comerica
CMA
| $10.1M | 0.09% |
195,811
+56,344
| +40% | +$2.71M |
|
281
Paychex
PAYX
$40.4B
| $10.1M | 0.09% |
237,231
-34,774
| -13% | -$1.48M |
|
|
PRE
282
DELISTED
PARTNERRE LTD
PRE
| $10M | 0.09% |
96,783
+41,205
| +74% | +$4.12M |
|
283
Brinker International
EAT
$8.02B
| $10M | 0.09% |
190,761
+8,742
| +5% | +$437K |
|
284
AZZ Inc
AZZ
$4.5B
| $9.93M | 0.09% |
222,257
-44,089
| -17% | -$1.9M |
|
285
GSK
GSK
$103B
| $9.91M | 0.09% |
148,444
-2,923
| -2% | -$198K |
|
286
SPDR Gold Trust
GLD
$131B
| $9.78M | 0.09% |
79,129
-38,370
| -33% | -$4.78M |
|
287
Tapestry
TPR
$28.8B
| $9.77M | 0.09% |
196,836
-8,491
| -4% | -$423K |
|
288
East-West Bancorp
EWBC
$17.9B
| $9.74M | 0.09% |
266,849
+64,023
| +32% | +$2.25M |
|
|
ISSI
289
DELISTED
INTEGRATED SILICON SOLUTN INC
ISSI
| $9.72M | 0.09% |
625,290
+104,199
| +20% | +$1.31M |
|
|
XLS
290
DELISTED
EXELIS INC COM STK
XLS
| $9.62M | 0.09% |
541,825
+374,194
| +223% | +$6.9M |
|
291
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.88B
| $9.58M | 0.09% |
+195,194
| New | +$9.28M |
|
292
PPG Industries
PPG
$25.9B
| $9.57M | 0.09% |
98,954
+19,958
| +25% | +$1.89M |
|
|
QCOR
293
DELISTED
QUESTCOR PHARMA INC
QCOR
| $9.56M | 0.09% |
147,268
-2,610
| -2% | -$167K |
|
|
RGP
294
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
| $9.53M | 0.09% |
350,001
+174,551
| +99% | +$4.67M |
|
295
Berkshire Hathaway Class A
BRK.A
$1.07T
| $9.37M | 0.09% |
50
+5
| +11% | +$878K |
|
296
Biogen
BIIB
$29.9B
| $9.3M | 0.09% |
30,426
-5,511
| -15% | -$1.75M |
|
|
ENDP
297
DELISTED
Endo International plc
ENDP
| $9.29M | 0.09% |
135,408
-22,852
| -14% | -$1.62M |
|
298
HF Sinclair
DINO
$15.9B
| $9.26M | 0.09% |
194,689
+119,400
| +159% | +$5.65M |
|
|
RKT
299
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $9.26M | 0.09% |
175,500
+980
| +0.6% | +$51.3K |
|
300
AMN Healthcare
AMN
$1.28B
| $9.24M | 0.09% |
672,309
+276,134
| +70% | +$3.97M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2014 Portfolio in Review
As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.
- Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
- Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
- Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
- Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
- Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
- Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
- Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.
Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.